Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Clearside Biomedical, Inc. (CLSD)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-05-20Dec-31-19Dec-31-18
   10-K8-K10-K8-K10-K8-K10-K10-K
Total revenues   [+]1.319.629.618.57.915.12.20.0
            Revenue growth  -95.5%5.9%274.7%23.0%263.3% 7143.3%-91.3%
Cost of goods sold  0.00.20.030.20.025.80.00.0
Gross profit  1.319.429.6-11.77.9-10.82.20.0
            Gross margin  100.0%99.0%100.0%-62.9%100.0%-71.4%100.0%100.0%
Selling, general and administrative   [+]31.611.830.211.725.810.832.514.7
Research and development         68.3
Other operating expenses  3.337.9 -22.70.3-3.60.5 
EBITDA   [+]       -82.8
            EBITDA margin  -2533.2%-154.2%-2.1%-3.4%-230.7%-119.0%-1416.0%-275853.3%
Depreciation and amortization         0.2
EBIT   [+]-33.6-30.3-0.6-0.6-18.2-17.9-30.8-82.9
            EBIT margin  -2533.2%-154.2%-2.1%-3.4%-230.7%-119.0%-1416.0%-276483.3%
Other income (expense), net  0.7-2.71.01.00.117.90.80.9
Pre-tax income  -32.9-32.90.40.4-18.20.0-30.8-82.8
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0% 0.0%0.0%
Net income  -32.9-32.90.40.4-18.2-18.2-30.8-82.8
            Net margin  -2482.8%-167.8%1.3%2.0%-230.7%-120.8%-1416.0%-276060.0%
   
Basic EPS   [+]($0.55)($0.55)$0.01$0.01($0.39)($0.39)($0.81)($2.69)
Diluted EPS   [+]($0.55)($0.55)$0.01$0.01($0.39)($0.39)($0.81)($2.69)
   
Shares outstanding (basic)   [+]60.260.258.558.546.546.538.230.7
Shares outstanding (diluted)   [+]60.260.259.959.946.546.538.230.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy